X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Torrent Pharma with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs PIRAMAL ENTERPRISES - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA PIRAMAL ENTERPRISES TORRENT PHARMA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 26.6 38.2 69.7% View Chart
P/BV x 6.5 3.8 171.3% View Chart
Dividend Yield % 3.1 0.6 479.7%  

Financials

 TORRENT PHARMA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-16
PIRAMAL ENTERPRISES
Mar-16
TORRENT PHARMA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1,7201,065 161.5%   
Low Rs1,134805 140.8%   
Sales per share (Unadj.) Rs394.5383.0 103.0%  
Earnings per share (Unadj.) Rs101.855.1 184.8%  
Cash flow per share (Unadj.) Rs116.374.1 157.1%  
Dividends per share (Unadj.) Rs40.0017.50 228.6%  
Dividend yield (eoy) %2.81.9 149.8%  
Book value per share (Unadj.) Rs200.3719.9 27.8%  
Shares outstanding (eoy) m169.22172.56 98.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.62.4 148.1%   
Avg P/E ratio x14.017.0 82.6%  
P/CF ratio (eoy) x12.312.6 97.2%  
Price / Book Value ratio x7.11.3 548.5%  
Dividend payout %39.331.8 123.7%   
Avg Mkt Cap Rs m241,435161,344 149.6%   
No. of employees `00010.93.8 287.9%   
Total wages/salary Rs m8,55916,898 50.6%   
Avg. sales/employee Rs Th6,129.617,472.6 35.1%   
Avg. wages/employee Rs Th785.84,466.9 17.6%   
Avg. net profit/employee Rs Th1,581.32,512.8 62.9%   
INCOME DATA
Net Sales Rs m66,76466,099 101.0%  
Other income Rs m2,1562,425 88.9%   
Total revenues Rs m68,92068,524 100.6%   
Gross profit Rs m27,20418,723 145.3%  
Depreciation Rs m2,4613,274 75.1%   
Interest Rs m1,8599,388 19.8%   
Profit before tax Rs m25,0418,485 295.1%   
Minority Interest Rs m03 -9.1%   
Prior Period Items Rs m01,593 0.0%   
Extraordinary Inc (Exp) Rs m-1,403457 -307.2%   
Tax Rs m6,4141,032 621.6%   
Profit after tax Rs m17,2249,506 181.2%  
Gross profit margin %40.728.3 143.9%  
Effective tax rate %25.612.2 210.6%   
Net profit margin %25.814.4 179.4%  
BALANCE SHEET DATA
Current assets Rs m46,62247,488 98.2%   
Current liabilities Rs m32,843104,362 31.5%   
Net working cap to sales %20.6-86.0 -24.0%  
Current ratio x1.40.5 312.0%  
Inventory Days Days7441 182.8%  
Debtors Days Days7951 154.5%  
Net fixed assets Rs m39,02926,532 147.1%   
Share capital Rs m846345 245.2%   
"Free" reserves Rs m31,400114,024 27.5%   
Net worth Rs m33,890124,221 27.3%   
Long term debt Rs m18,63775,812 24.6%   
Total assets Rs m90,136308,356 29.2%  
Interest coverage x14.51.9 760.2%   
Debt to equity ratio x0.50.6 90.1%  
Sales to assets ratio x0.70.2 345.5%   
Return on assets %21.26.1 345.5%  
Return on equity %50.87.7 664.1%  
Return on capital %48.510.0 487.3%  
Exports to sales %43.317.2 252.1%   
Imports to sales %6.96.6 104.0%   
Exports (fob) Rs m28,93411,362 254.7%   
Imports (cif) Rs m4,5844,364 105.0%   
Fx inflow Rs m29,18514,435 202.2%   
Fx outflow Rs m6,0215,183 116.2%   
Net fx Rs m23,1659,253 250.3%   
CASH FLOW
From Operations Rs m27,132-67,773 -40.0%  
From Investments Rs m-7,014-8,768 80.0%  
From Financial Activity Rs m-14,35276,199 -18.8%  
Net Cashflow Rs m5,767-342 -1,684.1%  

Share Holding

Indian Promoters % 71.5 52.9 135.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.0 4.0 175.5%  
FIIs % 12.6 26.6 47.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.8 16.5 53.3%  
Shareholders   26,511 93,274 28.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  WYETH LTD  ASTRAZENECA PHARMA  

Compare TORRENT PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; Auto Stocks Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the auto sector and banking sector witnessing maximum selling pressure.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Aug 17, 2017 12:20 PM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - SUN PHARMA COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS